chromosomal abnormalities in basal-like BC may suggest a functional link with expression of CT antigens [5] . On the basis of these concepts, it has been inferred that expression of CT antigens in TN BC may be associated with basal-like features, but no experimental data in support of this have been provided.
To explore the correlation between CT antigen expression in TNBC and basal-like tumors, we assessed the expression of MAGE-A antigens and basal-like associated markers, including epidermal growth factor receptor, p63, CK5, and CK14, in a group of TN primary BC samples collected at the Italian National Cancer Institute (Aviano, Italy). Consistent with the recent report from Curigliano et al. [3] , we found expression of MAGE-A proteins in (10/44) 23% of the samples ( Figure 1 ). As expected, we also found a frequent expression of basal-like markers, with 80% of the TN tumors expressing at least one of them. We failed, however, to detect a correlation between MAGE-A expression and any of the markers. Thus, expression of CT antigens, although frequent in TN tumors, does not correlate with a basal-like type, indicating that the precursors and or/molecular events giving rise to CT antigen-expressing and basal-like tumors are not identical. The molecular basis for the selective expression of CT antigens in HR-negative tumors, therefore, remains to be elucidated, along with the expression of CT antigens in relation to overexpression of human epidermal growth factor receptor 2. letters to the editor Annals of Oncology
